scholarly journals Long-Term Azathioprine Therapy in Two Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome.

1999 ◽  
Vol 187 (3) ◽  
pp. 273-278 ◽  
Author(s):  
Hiroshi Tanaka ◽  
Norio Onodera ◽  
Shinobu Waga
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Azathioprine Therapy ◽  
Steroid Dependent

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

2010 ◽  
Vol 25 (3) ◽  
pp. 539-544 ◽  
Author(s):  
Shuichiro Fujinaga ◽  
Daishi Hirano ◽  
Naoto Nishizaki ◽  
Koichi Kamei ◽  
Shuichi Ito ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Single Infusion ◽  
Steroid Dependent

scholarly journals Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment

Medicine ◽  
2014 ◽  
Vol 93 (29) ◽  
pp. e300 ◽  
Author(s):  
Yuko Iwabuchi ◽  
Takashi Takei ◽  
Takahito Moriyama ◽  
Mitsuyo Itabashi ◽  
Kosaku Nitta
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Adult Patients ◽  
Steroid Dependent ◽  
Long Term Prognosis

scholarly journals Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults

2012 ◽  
Vol 28 (5) ◽  
pp. 1225-1232 ◽  
Author(s):  
T. Takei ◽  
M. Itabashi ◽  
T. Moriyama ◽  
C. Kojima ◽  
S. Shiohira ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Single Dose ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Steroid Dependent

LONG-TERM OUTCOME FOR CHILDREN WITH MINIMAL-CHANGE NEPHROTIC SYNDROME

The Lancet ◽  
1985 ◽  
Vol 325 (8425) ◽  
pp. 368-370 ◽  
Author(s):  
R.S. Trompeter ◽  
J. Hicks ◽  
B.W. Lloyd ◽  
R.H.R. White ◽  
J.S. Cameron
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term outcome of biopsy-proven minimal-change nephrotic syndrome in Chinese children

2013 ◽  
Vol 15 (1) ◽  
pp. 22-27 ◽  
Author(s):  
Vickie Wai-Ki Kwong ◽  
Bonnie Ching-Ha Kwan ◽  
Kai-Ming Chow ◽  
Chi-Bon Leung ◽  
Philip Kam-Tao Li ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Chinese Children ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine

2019 ◽  
Vol 34 (11) ◽  
pp. 2417-2421
Author(s):  
Shuichiro Fujinaga ◽  
Daishi Hirano ◽  
Tomohiko Nishino ◽  
Chisato Umeda ◽  
Yoshitaka Watanabe ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Mycophenolate Mofetil ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Japanese Children ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-Term Outcome of Biopsy-Proven, Frequently Relapsing Minimal-Change Nephrotic Syndrome in Children

2009 ◽  
Vol 4 (10) ◽  
pp. 1593-1600 ◽  
Author(s):  
Henriette A.C. Kyrieleis ◽  
Marije M. Löwik ◽  
Ilse Pronk ◽  
Hans R.M. Cruysberg ◽  
Jan A.M. Kremer ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series

2018 ◽  
Vol 8 (3) ◽  
pp. 230-237 ◽  
Author(s):  
Ryosuke Usui ◽  
Yohei Tsuchiya ◽  
Kosaku Nitta ◽  
Minako Koike
Keyword(s):  
Nephrotic Syndrome ◽  
Low Dose ◽  
Chemotherapy Regimen ◽  
Case Series ◽  
Minimal Change Nephrotic Syndrome ◽  
Minimal Change ◽  
Cell Hyperplasia ◽  
Conventional Dose ◽  
Steroid Dependent ◽  
Refractory Nephrotic Syndrome

The frequency of using rituximab to treat refractory nephrotic syndrome has recently been increasing, and the conventional dose of rituximab used to treat it, 375 mg/m2 body surface area once weekly for 4 weeks, has been modelled on the chemotherapy regimen for B-cell non-Hodgkin’s lymphoma. The dose and intervals of rituximab in refractory nephrotic syndrome remain controversial. Clear lymphoma cell hyperplasia is seen in lymphoma patients, but not in nephrotic syndrome patients. Since we thought that it might be possible to reduce the dose of rituximab if only used for the purpose of depleting CD20-positive B cells in nephrotic patients’ peripheral blood, we tried semiannually with a single fixed rituximab dose of 100 mg/body, and a complete remission was attained in 3 cases without treatment with prednisolone or cyclosporine. Our report strongly suggests considering appropriate dose and interval of rituximab therapy in the treatment of steroid-dependent nephrotic syndrome.

Sign in / Sign up

Export Citation Format

Share Document